StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research note published on Monday morning. The brokerage issued a buy rating on the stock.

Mannatech Price Performance

Shares of MTEX opened at $8.40 on Monday. The firm has a fifty day moving average price of $7.79 and a 200 day moving average price of $7.54. The stock has a market cap of $15.79 million, a PE ratio of -10.37 and a beta of 1.17. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

Insider Buying and Selling at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the transaction, the director now owns 54,721 shares in the company, valued at approximately $424,087.75. This represents a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 41.50% of the stock is owned by company insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.